<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20193" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cyclic Neutropenia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zergham</surname>
            <given-names>Azka S.</given-names>
          </name>
          <aff>Larkin Community Hospital- Hialeah, Florida</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Acharya</surname>
            <given-names>Utkarsh</given-names>
          </name>
          <aff>Dana Farber Cancer Institute / Brigham</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mukkamalla</surname>
            <given-names>Shiva Kumar R.</given-names>
          </name>
          <aff>Presbyterian Healthcare Services</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Azka Zergham declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Utkarsh Acharya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shiva Kumar Mukkamalla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20193.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Cyclic neutropenia is a very rare hematological condition characterized by regular fluctuations in blood neutrophil counts, leading to periodic neutropenia with a 21-day turnover frequency. This activity reviews the evaluation and management of cyclic neutropenia and highlights the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of cyclic neutropenia medical conditions and emergencies.</p></list-item><list-item><p>Outline and explain the appropriate history, physical, and evaluation of cyclic neutropenia.</p></list-item><list-item><p>Review the treatment and management options available for cyclic neutropenia.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance the management of cyclic neutropenia and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20193&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20193">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20193.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Neutrophils play a vital role in our immune defenses by ingesting, killing, and digesting invading microorganisms. Failure to carry out this role results in immunodeficiency, which manifests itself in the form of recurrent infections.<xref ref-type="bibr" rid="article-20193.r1">[1]</xref>&#x000a0;Common causes of neutropenia include autoimmune diseases, drug reactions, chemotherapy, and hereditary disorders.<xref ref-type="bibr" rid="article-20193.r2">[2]</xref>&#x000a0;Cyclic neutropenia is a very rare hematological condition and is characterized by regular fluctuations in blood neutrophil counts, leading to periodic neutropenia with a 21-day turnover frequency.<xref ref-type="bibr" rid="article-20193.r2">[2]</xref><xref ref-type="bibr" rid="article-20193.r3">[3]</xref>&#x000a0;It is now considered an autosomal dominant disease caused by ELANE gene mutations.<xref ref-type="bibr" rid="article-20193.r4">[4]</xref> The symptoms and clinical manifestation of cyclic neutropenia may range from mild to severe, depending on the degree and duration of neutropenia. The absolute neutrophil count can drop to zero, and these extremely low counts may last for up to three to five days.<xref ref-type="bibr" rid="article-20193.r5">[5]</xref></p>
      </sec>
      <sec id="article-20193.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Recent research in the field of molecular biology has permitted the discovery of the underlying genetic basis for many inherited diseases.<xref ref-type="bibr" rid="article-20193.r5">[5]</xref>&#x000a0;Genetic sequencing in patients with cyclic neutropenia has highlighted mutations at locus 19q13 in the gene for neutrophil elastase. This gene is now referred to as ELANE, and the mutations are consistently found to be present in all patients suffering from cyclic neutropenia but not in their unaffected family members. Some authorities refer to this condition as&#x000a0;ELANE-associated neutropenia.<xref ref-type="bibr" rid="article-20193.r5">[5]</xref><xref ref-type="bibr" rid="article-20193.r6">[6]</xref></p>
      </sec>
      <sec id="article-20193.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Cyclic neutropenia is an autosomal dominant disease, so it affects males and females in equal proportions and is familial in some.<xref ref-type="bibr" rid="article-20193.r4">[4]</xref> Although the disorder is often discovered in young children, the condition lasts throughout the lifetime of the patient.<xref ref-type="bibr" rid="article-20193.r7">[7]</xref>&#x000a0;There have also been reports of cases where patients presented with acquired cyclic neutropenia, and the disease onset was later in life.<xref ref-type="bibr" rid="article-20193.r8">[8]</xref></p>
      </sec>
      <sec id="article-20193.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Neutrophils play a pivotal role in the immune defense of the body. Once the neutrophil count is below 1 x&#x000a0;10^9/L, the patient becomes susceptible to recurrent infections.<xref ref-type="bibr" rid="article-20193.r1">[1]</xref>&#x000a0;The exact pathophysiological basis of cyclic neutropenia remains unknown, but several studies in the 1950s by&#x000a0;Page and Good&#x000a0;concluded that the interrupted cell production by the bone marrow may be the main underlying cause of cyclic neutropenia.<xref ref-type="bibr" rid="article-20193.r9">[9]</xref> Subsequent studies also showed that there are cyclic fluctuations in all blood cells. This suggests that the intrinsic defect leading to the disorder is in the hematopoietic stem cells.<xref ref-type="bibr" rid="article-20193.r10">[10]</xref></p>
      </sec>
      <sec id="article-20193.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Cyclic neutropenia presents with a periodically decreased number of neutrophils in the bone marrow and circulation during an attack.<xref ref-type="bibr" rid="article-20193.r2">[2]</xref>&#x000a0;The absolute neutrophil count is usually &#x0003c;.2 x 10^9/L.<xref ref-type="bibr" rid="article-20193.r11">[11]</xref>&#x000a0;Acquired cyclic neutropenia in adults may show a clonal proliferation of large granular lymphocytes.<xref ref-type="bibr" rid="article-20193.r3">[3]</xref></p>
      </sec>
      <sec id="article-20193.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with cyclic neutropenia usually have a periodic decrease in absolute neutrophil count (often &#x0003c;.2 x10^9/L), and present with a clinical syndrome characterized by recurrent fever, oral mucosal ulcers, and respiratory infections.<xref ref-type="bibr" rid="article-20193.r11">[11]</xref> Opportunistic infections appear during a reduction in absolute neutrophil count and manifest clinically as fever, oral ulcers, gingivitis, tonsillitis, pharyngitis, dermatological infections, and swollen lymph nodes.<xref ref-type="bibr" rid="article-20193.r12">[12]</xref><xref ref-type="bibr" rid="article-20193.r13">[13]</xref><xref ref-type="bibr" rid="article-20193.r14">[14]</xref> Patients also exhibit periodontitis with alveolar bone loss during childhood. It has been observed that the systemic symptoms of cyclic neutropenia such as recurrent fevers diminish after adolescence, but even adult patients continue to experience oral ulcers, gingivitis, periodontitis, and other infections.<xref ref-type="bibr" rid="article-20193.r15">[15]</xref>&#x000a0;Infections usually respond well to antibiotics. Severe infections are very rare. However, long-term follow-up of patients showed that the life-threatening complications encountered were the occurrence of spontaneous peritonitis, segmental bowel necrosis, and septicemia.<xref ref-type="bibr" rid="article-20193.r8">[8]</xref></p>
      </sec>
      <sec id="article-20193.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis and evaluation of cyclic neutropenia are based on clinical symptoms, duration, history of hereditary inheritance, white cell counts, immune function, bone marrow alterations, and weekly differential leukocyte count (DLC). Investigations such as complete blood count, bone marrow biopsy, histopathological studies, tumoral markers, levels of cytokines (granulocyte-colony stimulating factor), chest x-ray, diagnostic&#x000a0;ultrasound, and computerized tomography (CT) scan should be done to rule out other immunodeficiency disorders. DNA studies can be carried out as a confirmatory test for most genetic disorders, including cyclic neutropenia.<xref ref-type="bibr" rid="article-20193.r1">[1]</xref></p>
      </sec>
      <sec id="article-20193.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The mainstay of treatment and management includes regular monitoring of blood counts, prevention and control of infections through judicious use of antibiotics, oral and dental care, and patient education. Alternate-day corticosteroid regimes have been used successfully to treat recurrent signs and symptoms.<xref ref-type="bibr" rid="article-20193.r8">[8]</xref><xref ref-type="bibr" rid="article-20193.r12">[12]</xref> Most children suffering from severe congenital neutropenia require the long-term administration of granulocyte-colony stimulating factor (G-CSF).<xref ref-type="bibr" rid="article-20193.r16">[16]</xref><xref ref-type="bibr" rid="article-20193.r17">[17]</xref>. G-CSF is now considered a remarkably safe and efficacious treatment for preventing infections and improving the quality of life in patients suffering from cyclic neutropenia.<xref ref-type="bibr" rid="article-20193.r18">[18]</xref>&#x000a0;A recent study has suggested that the combination therapy of G-CSF and high-dose immunoglobulin might be an effective treatment for cyclic neutropenia.<xref ref-type="bibr" rid="article-20193.r19">[19]</xref>&#x000a0;Hematopoietic stem cell transplantation (HSCT) is still the ultimate radical treatment, which can permanently correct cyclic neutropenia and is the best long-term option for patients who do not respond to G-CSF treatment.<xref ref-type="bibr" rid="article-20193.r17">[17]</xref></p>
      </sec>
      <sec id="article-20193.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Cyclic neutropenia may have a similar presentation to several causes of recurrent fever, such as recurrent tonsillitis, infectious diseases, juvenile idiopathic arthritis, Beh&#x000e7;et's disease, and familial Mediterranean fever syndrome.<xref ref-type="bibr" rid="article-20193.r20">[20]</xref></p>
          </list-item>
        </list>
        <p>Rare disorders with a presentation similar to cyclic neutropenia are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Marshall syndrome (MS) is a recurrent fever syndrome characterized by fever at 3-8 weeks intervals, cervical adenopathy, pharyngitis, and aphthous ulcers. MS is a diagnosis of exclusion.<xref ref-type="bibr" rid="article-20193.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p>PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) is a non-hereditary autoinflammatory disease, presenting with recurrent fevers lasting for 3&#x000a0;to 6 days duration, accompanied by aphthous ulcers, pharyngitis, tonsillitis, and cervical lymphadenitis.<xref ref-type="bibr" rid="article-20193.r21">[21]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20193.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The clinical course of cyclic neutropenia is usually benign compared with other conditions with neutropenia.<xref ref-type="bibr" rid="article-20193.r8">[8]</xref>&#x000a0;The systemic symptoms of cyclic neutropenia such as recurrent fevers usually diminish after adolescence but even adult patients continue to experience oral ulcers, gingivitis, periodontitis, and other infections.<xref ref-type="bibr" rid="article-20193.r15">[15]</xref>&#x000a0;Many patients exhibit periodontitis with alveolar bone loss, during childhood.</p>
      </sec>
      <sec id="article-20193.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Studies show that serious long-term complications such as&#x000a0;septicemia, spontaneous peritonitis, and segmental bowel necrosis may occur in some patients suffering from cyclic neutropenia.<xref ref-type="bibr" rid="article-20193.r8">[8]</xref></p>
      </sec>
      <sec id="article-20193.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education&#x000a0;about careful oral and dental care and the judicious use of antibiotics are the mainstays of management for cyclic neutropenia. The importance of oral hygiene and regular monthly dental visits should be explained to the patient.<xref ref-type="bibr" rid="article-20193.r22">[22]</xref></p>
      </sec>
      <sec id="article-20193.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Cyclic neutropenia is a distinctive disorder of unknown etiology, characterized by regularly cycling episodes of neutropenia, which occur about every three weeks.<xref ref-type="bibr" rid="article-20193.r8">[8]</xref>&#x000a0;Cyclic neutropenia frequently poses a diagnostic dilemma. These patients may exhibit non-specific signs and symptoms such as recurrent fever, oral ulcers, and infections. The cause of recurrent fever may be due to a myriad of diagnoses including, recurrent tonsillitis, infectious diseases, juvenile idiopathic arthritis, Beh&#x000e7;et's disease, and familial Mediterranean fever syndrome. The physical exam may reveal the fever, aphthous ulcers, and periodontitis, but the cause is difficult to know without proper diagnostic studies. Over the past few years, hematologists, immunologists, and geneticists have collaborated to bring about the discovery of the genetic and biochemical basis of cyclic neutropenia.<xref ref-type="bibr" rid="article-20193.r23">[23]</xref>&#x000a0;While the hematologist is almost always involved in the care of patients with cyclic neutropenia, it is important to consult with an interprofessional team of specialists that include an immunologist, geneticist, radiologist, and dentist. A collaboration of&#x000a0;the team, interprofessional communication, care coordination, regular patient follow-up visits, including lab tests, periodic dental cleaning, and judicious use of antibiotics are recommended to improve patient outcomes.<xref ref-type="bibr" rid="article-20193.r24">[24]</xref></p>
      </sec>
      <sec id="article-20193.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20193&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20193">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/blood-disorders/cyclic-neutropenia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20193">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20193/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20193">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20193.s16">
        <title>References</title>
        <ref id="article-20193.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Justiz Vaillant</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Rout</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Zito</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <chapter-title>Neutropenia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>6</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">29939524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aota</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamanoi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Momota</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ninomiya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yumoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Azuma</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Management of tooth extraction in a patient with ELANE gene mutation-induced cyclic neutropenia: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>98</volume>
            <issue>39</issue>
            <fpage>e17372</fpage>
            <pub-id pub-id-type="pmid">31574885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dale</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Hammond</surname>
                <given-names>WP</given-names>
              </name>
            </person-group>
            <article-title>Cyclic neutropenia: a clinical review.</article-title>
            <source>Blood Rev</source>
            <year>1988</year>
            <month>Sep</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>178</fpage>
            <page-range>178-85</page-range>
            <pub-id pub-id-type="pmid">3052663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horwitz</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Grimes</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Tidwell</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.</article-title>
            <source>Hematol Oncol Clin North Am</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-41, vii</page-range>
            <pub-id pub-id-type="pmid">23351986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dale</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Understanding, treating and avoiding hematological disease: better medicine through mathematics?</article-title>
            <source>Bull Math Biol</source>
            <year>2015</year>
            <month>May</month>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>739</fpage>
            <page-range>739-57</page-range>
            <pub-id pub-id-type="pmid">25213154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horwitz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Person</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Aprikyan</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Dale</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.</article-title>
            <source>Nat Genet</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>433</fpage>
            <page-range>433-6</page-range>
            <pub-id pub-id-type="pmid">10581030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>REIMANN</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>DeBERARDINIS</surname>
                <given-names>CT</given-names>
              </name>
            </person-group>
            <article-title>Periodic (cyclic) neutropenia, an entity; a collection of 16 cases.</article-title>
            <source>Blood</source>
            <year>1949</year>
            <month>Oct</month>
            <volume>4</volume>
            <issue>10</issue>
            <fpage>1109</fpage>
            <page-range>1109-16</page-range>
            <pub-id pub-id-type="pmid">18139383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wright</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Dale</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Fauci</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Human cyclic neutropenia: clinical review and long-term follow-up of patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1981</year>
            <month>Jan</month>
            <volume>60</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-13</page-range>
            <pub-id pub-id-type="pmid">7453561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>PAGE</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>GOOD</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Studies on cyclic neutropenia; a clinical and experimental investigation.</article-title>
            <source>AMA J Dis Child</source>
            <year>1957</year>
            <month>Dec</month>
            <volume>94</volume>
            <issue>6</issue>
            <fpage>623</fpage>
            <page-range>623-61</page-range>
            <pub-id pub-id-type="pmid">13478297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guerry</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dale</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Omine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Periodic hematopoiesis in human cyclic neutropenia.</article-title>
            <source>J Clin Invest</source>
            <year>1973</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>12</issue>
            <fpage>3220</fpage>
            <page-range>3220-30</page-range>
            <pub-id pub-id-type="pmid">4750451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dale</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Cyclic and chronic neutropenia: an update on diagnosis and treatment.</article-title>
            <source>Clin Adv Hematol Oncol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>9</volume>
            <issue>11</issue>
            <fpage>868</fpage>
            <page-range>868-9</page-range>
            <pub-id pub-id-type="pmid">22252620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boo</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Nam</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <article-title>Cyclic neutropenia with a novel gene mutation presenting with a necrotizing soft tissue infection and severe sepsis: case report.</article-title>
            <source>BMC Pediatr</source>
            <year>2015</year>
            <month>Apr</month>
            <day>02</day>
            <volume>15</volume>
            <fpage>34</fpage>
            <pub-id pub-id-type="pmid">25880377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Germeshausen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Deerberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Reimer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kratz</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Ballmaier</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia.</article-title>
            <source>Hum Mutat</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>905</fpage>
            <page-range>905-14</page-range>
            <pub-id pub-id-type="pmid">23463630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makaryan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Zeidler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bolyard</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Skokowa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rodger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kelley</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Boxer</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Bonilla</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Newburger</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Shimamura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Welte</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dale</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>The diversity of mutations and clinical outcomes for ELANE-associated neutropenia.</article-title>
            <source>Curr Opin Hematol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-11</page-range>
            <pub-id pub-id-type="pmid">25427142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ye</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Carlsson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wondimu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fahl&#x000e9;n</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karlsson-Sj&#x000f6;berg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Engstrand</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yucel-Lindberg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mod&#x000e9;er</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>P&#x000fc;tsep</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Mutations in the ELANE gene are associated with development of periodontitis in patients with severe congenital neutropenia.</article-title>
            <source>J Clin Immunol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>936</fpage>
            <page-range>936-45</page-range>
            <pub-id pub-id-type="pmid">21796505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenberg</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Zeidler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bolyard</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Alter</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Bonilla</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Boxer</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Dror</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kinsey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Newburger</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Shimamura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Welte</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dale</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.</article-title>
            <source>Br J Haematol</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>150</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-9</page-range>
            <pub-id pub-id-type="pmid">20456363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenberg</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Alter</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Bolyard</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Bonilla</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Boxer</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Cham</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kannourakis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kinsey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schwinzer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zeidler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Welte</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dale</surname>
                <given-names>DC</given-names>
              </name>
              <collab>Severe Chronic Neutropenia International Registry</collab>
            </person-group>
            <article-title>The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.</article-title>
            <source>Blood</source>
            <year>2006</year>
            <month>Jun</month>
            <day>15</day>
            <volume>107</volume>
            <issue>12</issue>
            <fpage>4628</fpage>
            <page-range>4628-35</page-range>
            <pub-id pub-id-type="pmid">16497969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dale</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Bolyard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marrero</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Makaryan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bonilla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Newburger</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shimamura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boxer</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Spiekerman</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Dec</month>
            <day>07</day>
            <volume>377</volume>
            <issue>23</issue>
            <fpage>2290</fpage>
            <page-range>2290-2292</page-range>
            <pub-id pub-id-type="pmid">29211670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishida</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Higaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tauchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yokota</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsuda</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Disappearance of neutrophil fluctuations in a child with cyclic neutropenia by combination therapy of granulocyte colony-stimulating factor and high-dose immunoglobulin.</article-title>
            <source>Acta Paediatr Jpn</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>388</fpage>
            <page-range>388-90</page-range>
            <pub-id pub-id-type="pmid">7544058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trandafir</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Chiriac</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Diaconescu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ioniuc</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Miron</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rusu</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Marshall syndrome in a young child, a reality: Case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>95</volume>
            <issue>44</issue>
            <fpage>e5065</fpage>
            <pub-id pub-id-type="pmid">27858841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kusuhara</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome].</article-title>
            <source>Nihon Rinsho Meneki Gakkai Kaishi</source>
            <year>2011</year>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>401</fpage>
            <page-range>401-7</page-range>
            <pub-id pub-id-type="pmid">22041428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ishihara</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ogata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shimono</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Oral manifestations of cyclic neutropenia in a Japanese child: case report with a 5-year follow-up.</article-title>
            <source>Pediatr Dent</source>
            <year>2003</year>
            <season>Jul-Aug</season>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>383</fpage>
            <page-range>383-8</page-range>
            <pub-id pub-id-type="pmid">13678105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badolato</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fontana</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Savoldi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Congenital neutropenia: advances in diagnosis and treatment.</article-title>
            <source>Curr Opin Allergy Clin Immunol</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>513</fpage>
            <page-range>513-21</page-range>
            <pub-id pub-id-type="pmid">15640692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20193.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pernu</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Pajari</surname>
                <given-names>UH</given-names>
              </name>
              <name>
                <surname>Lanning</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The importance of regular dental treatment in patients with cyclic neutropenia. Follow-up of 2 cases.</article-title>
            <source>J Periodontol</source>
            <year>1996</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>454</fpage>
            <page-range>454-9</page-range>
            <pub-id pub-id-type="pmid">8708974</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
